4-클로로-7-메톡시퀴놀린-6-카르복사미드

4-Chloro-7-methoxyquinoline-6-carboxamide

HCID 22936418

기본 정보

CAS
417721-36-9
표준 SMILES
COc1cc2nccc(Cl)c2cc1C(N)=O
InChIKey
ZBTVNIDMGKZSGC-UHFFFAOYSA-N
분자식
C11H9ClN2O2
평균 분자량
236.65 g/mol
단동위원소 질량
236.03525521

이름 및 식별자

우선 이름
4-Chloro-7-methoxyquinoline-6-carboxamide
IUPAC
4-chloro-7-methoxyquinoline-6-carboxamide
현지명
4-클로로-7-메톡시퀴놀린-6-카르복사미드
영어명
4-chloro-7-Methoxyquinoline-6-carboxaMide
분자식
C11H9ClN2O2
분자량
236.65

이름 및 동의어

4-chloro-7-methoxyquinoline-6-carboxamide417721-36-9DTXSID10629105RefChem:291930DTXCID105798587-methoxy-4-chloro-quinoline-6-carboxamideMFCD131922564-Chloro-7-methoxy-6-quinolinecarboxamideSCHEMBL1323767AKOS025146814AKOS032949975Lenvatinib Impurity B
이름 더 보기
4-클로로-7-메톡시퀴놀린-6-카르복사미드lenvaint-Esynthesis-024synthesis-1-014ine-6-carboxamideoro-7-methoxyquinoLLenvatinib Impurity 50Lenvatinib Impurity LFS-BLenvatinib chloro impurity
Lenvatinib Impurity 206-Quinolinecarboxamide, 4-chloro-7-methoxy-AMY474BCP09852Lenvatinib Impurity B6AZY53UFA4SCHEMBL31218187DS-8955

데이터베이스 식별자

CAS
417721-36-9
PubChem CID
22936418
DTXSID
DTXSID10629105
UNII
6AZY53UFA4
EC Number
992-196-8
Nikkaji
J2.661.439B

물성

구조 계산 물성

XLogP
1.7
극성 표면적
65.2 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
3
회전 가능 결합 수
2
무거운 원자 수
16

물리화학적 성질

녹는점
205 °C · >205°C (dec.)
끓는 점
426.7 · 426.7±45.0 °C(Predicted)
밀도
1.38 · 1.380±0.06 g/cm3(Predicted)
저장 조건
2 · under inert gas (nitrogen or Argon) at 2-8°C
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨)
산도 계수 (pKa)
15.28 · 15.28±0.30(Predicted)

안전 및 규제

GHS 분류

GHS Classification · 4건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (100%)

안전 데이터

HS 번호
2933499090

화학 및 산업

응용 분야 · 2건

개요4-chloro-7-Methoxyquinoline-6-carboxaMide is a pharmaceutical intermediate compound used in the preparation of Lenvatinib, an oral multi-receptor tyrosine kinase inhibitor approved by the FDA for the treatment of radioiodine-refractory differentiated thyroid cancer (DTC), unresectable (DTC), unresectable hepatocellular carcinoma (HCC), and advanced renal cell carcinoma (RCC).

용도Pharmaceutical Intermediates. 4-chloro-7-Methoxyquinoline-6-carboxaMide is used as an intermediate for synthesizing Lenvatinibis.

공급사100 곳

河北创海生物科技有限公司+86-86-13131129325 · [email protected]
Hebei Yanxi Chemical Co., Ltd.+86-17531190177 · [email protected]
北京安司莫森技术有限公司010-82954736 13391601435 · [email protected]
北京华威锐科化工有限公司0757-86329057 18934348241 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]

관련 반응

29건

화합물 노트

불러오는 중…